Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Edoxaban vs DAPT for Prevention of Leaflet Thrombosis Post-TAVR
NCT03284827Phase 4Completed
- Sponsor
- Duk-Woo Park
- Start
- Mar 2018
- Primary completion
- Oct 2021
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 4 trial of edoxaban in Leaflet thrombosis, cerebral embolism, sponsored by Duk-Woo Park. Started Mar 2018; status: completed.
02
Drugs
edoxaban
03
Conditions
Leaflet thrombosiscerebral embolism
Beyond the preview
Go deeper on NCT03284827.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03284827.